More Life Sciences Headlines
How Dolly Parton helped fund Moderna’s COVID-19 vaccine at the height of the pandemic
Parton, who died Tuesday, was known for her philanthropic endeavors, including a donation that helped fund early research into the vaccine.
POWER PLAY
Why one key state Senate race is pitting Boston’s life science industry against real estate developers
Why life science leaders are backing Daniel Lander in his challenge of veteran state Senator Will Brownsberger.
Biotech lost jobs for the first time in two decades. But things might be on the upswing.
After a years-long slump, biopharma has come roaring back in 2026, as much of the more recent data in the report illustrates.
Worcester biomedical lab receives USDA warning over improper handling of monkeys
A federal report concluded that Biomere violated the Animal Welfare Act in incidents including 16 monkeys over roughly a year.
Moderna just made a huge leap forward in the world of cancer vaccines. Here’s what to know.
In addition to melanoma, Moderna and Merck are conducting trials with personalized injections to fight types of bladder, kidney, and lung cancers.
A ‘paradigm shift’: Moderna cancer vaccine results could herald new world of treatment
The vaccine, tailor-made to the genetic sequence of a patient’s cancer and paired with existing treatment, has the potential to be a game-changer.
Sanofi to lay off 229 workers in Mass., a year after $9.1 billion biotech acquisition
The layoffs were disclosed just over a year after Sanofi acquired Blueprint Medicines.
STAT
Scientist-turned-biotech executive Greg Verdine is notching some wins, and enjoying it
“I’m on a roll this year,” he said. “I planted a lot of seeds way back when, and they’ve really started to bear fruit.”